Chemotherapy and radiation treatments for cancer and other conditions can damage fertility and reduce or eliminate a patient’s ability to have children in the future. The good news is that improved treatments have dramatically increased cancer survival rates. Therefore, issues affecting quality of life after cure (including fertility) are increasingly important to survivors. Age, genetics, surgery, injury, gender affirming treatments and other factors can also impact fertility.
Through the Center for Fertility and Reproductive Endocrinology at Magee-Womens Hospital of UPMC, the Fertility Preservation Program in Pittsburgh provides the following fertility care services for children and/or adults:
- semen cryopreservation
- embryo cryopreservation
- embryo cryopreservation using donor sperm
- oocyte cryopreservation
- testicular tissue freezing (with approval of the Institutional Review Board of the University of Pittsburgh)
- ovarian tissue freezing (with approval of the Institutional Review Board of the University of Pittsburgh)
The Fertility Preservation Program of Pittsburgh is committed to:
- educating patients and their physicians about the reproductive consequences of chemotherapy and radiation treatments for cancer or other conditions;
- providing state of the art reproductive technologies to preserve fertility and treat infertility;
- pioneering new reproductive technologies to preserve fertility and treat infertility;
- rapidly translating these new technologies to the clinic, and;
- training the next generation of clinicians and researchers in the rapidly evolving discipline of fertility preservation.